Table of Content

Table of Contents

Global GM1 Gangliosidosis Treatment Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global GM1 Gangliosidosis Treatment Market by Value
2.2.1 Global GM1 Gangliosidosis Treatment Revenue by Type
2.2.2 Global GM1 Gangliosidosis Treatment Market by Value (%)
2.3 Global GM1 Gangliosidosis Treatment Market by Production
2.3.1 Global GM1 Gangliosidosis Treatment Production by Type
2.3.2 Global GM1 Gangliosidosis Treatment Market by Production (%)

3. The Major Driver of GM1 Gangliosidosis Treatment Industry
3.1 Historical & Forecast Global GM1 Gangliosidosis Treatment Demand
3.2 Largest Application for GM1 Gangliosidosis Treatment (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional GM1 Gangliosidosis Treatment Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of GM1 Gangliosidosis Treatment Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US GM1 Gangliosidosis Treatment Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe GM1 Gangliosidosis Treatment Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China GM1 Gangliosidosis Treatment Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan GM1 Gangliosidosis Treatment Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India GM1 Gangliosidosis Treatment Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea GM1 Gangliosidosis Treatment Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia GM1 Gangliosidosis Treatment Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global GM1 Gangliosidosis Treatment Average Price Trend
12.1 Market Price for Each Type of GM1 Gangliosidosis Treatment in US (2018-2022)
12.2 Market Price for Each Type of GM1 Gangliosidosis Treatment in Europe (2018-2022)
12.3 Market Price for Each Type of GM1 Gangliosidosis Treatment in China (2018-2022)
12.4 Market Price for Each Type of GM1 Gangliosidosis Treatment in Japan (2018-2022)
12.5 Market Price for Each Type of GM1 Gangliosidosis Treatment in India (2018-2022)
12.6 Market Price for Each Type of GM1 Gangliosidosis Treatment in Korea (2018-2022)
12.7 Market Price for Each Type of GM1 Gangliosidosis Treatment in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 GM1 Gangliosidosis Treatment Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of GM1 Gangliosidosis Treatment

14. GM1 Gangliosidosis Treatment Competitive Landscape
14.1 Axovant Gene Therapies Ltd
14.1.1 Axovant Gene Therapies Ltd Company Profiles
14.1.2 Axovant Gene Therapies Ltd Product Introduction
14.1.3 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Passage Bio and Lysogene
14.2.1 Passage Bio and Lysogene Company Profiles
14.2.2 Passage Bio and Lysogene Product Introduction
14.2.3 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of GM1 Gangliosidosis Treatment Industry (Volume)
Figure 2. GM1 Gangliosidosis Treatment Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by GM1 Gangliosidosis Treatment Revenue in 2022
Figure 5. US GM1 Gangliosidosis Treatment Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe GM1 Gangliosidosis Treatment Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China GM1 Gangliosidosis Treatment Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan GM1 Gangliosidosis Treatment Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India GM1 Gangliosidosis Treatment Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea GM1 Gangliosidosis Treatment Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia GM1 Gangliosidosis Treatment Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. GM1 Gangliosidosis Treatment Revenue, by Type (Million USD) (2018-2028)
Table 4. GM1 Gangliosidosis Treatment Production, by Type (K Unit) (2018-2028)
Table 5. GM1 Gangliosidosis Treatment Demand (K Unit) by Application (2018-2028)
Table 6. GM1 Gangliosidosis Treatment Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top GM1 Gangliosidosis Treatment Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US GM1 Gangliosidosis Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe GM1 Gangliosidosis Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China GM1 Gangliosidosis Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan GM1 Gangliosidosis Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India GM1 Gangliosidosis Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea GM1 Gangliosidosis Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia GM1 Gangliosidosis Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of GM1 Gangliosidosis Treatment in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of GM1 Gangliosidosis Treatment in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of GM1 Gangliosidosis Treatment in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of GM1 Gangliosidosis Treatment in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of GM1 Gangliosidosis Treatment in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of GM1 Gangliosidosis Treatment in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of GM1 Gangliosidosis Treatment in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Axovant Gene Therapies Ltd Profiles
Table 61. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Introduction
Table 62. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Axovant Gene Therapies Ltd Strategic initiatives
Table 64. Passage Bio and Lysogene Profiles
Table 65. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Introduction
Table 66. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Passage Bio and Lysogene Strategic initiatives